Additionally, another study demonstrated that C1GALT1 was overexpressed in 85% of pancreatic ductal adenocarcinoma tumors compared to adjacent non‐tumor tissues and was associated with poor survival outcomes in these patients. The gene discussed is C1GALT1; the disease is pancreatic ductal adenocarcinoma.